格特隐球菌感染的临床特征与实验室研究进展

doi:10.3969/j.issn.1673-8640.2017.011.028

摘要/Abstract

摘要：

格特隐球菌主要感染免疫力正常人并以肺部感染为主,格特隐球菌感染的临床特征、治疗、预后、影像学特点、实验室检查等均与新生隐球菌有所不同。文章对格特隐球菌感染的临床特征和实验室检查方法作一综述。

Abstract:

Cryptococcus gattii predominantly infects immunocompetent persons,and mainly leads to pulmonary infection. The clinical characteristics of Cryptococcus gattii infection,treatment and prognosis,imaging and laboratory examination are different from those of Cryptococcus neoformans. This review focuses on the clinical and laboratory characteristics of Cryptococcus gattii infection.

Key words: Cryptococcus gattii, Clinical characteristic, Laboratory examination

中图分类号:

R446.5

金亮, 沈定霞. 格特隐球菌感染的临床特征与实验室研究进展[J]. 检验医学, 2017, 32(11): 1065-1069.

JIN Liang, SHEN Dingxia. Research progress in the clinical characteristics of Cryptococcus gattii infection and its determination[J]. Laboratory Medicine, 2017, 32(11): 1065-1069.

参考文献 37

[1]	KWON-CHUNG K J,BOEKHOUT T,FELL J W,et al. Proposal to conserve the name Cryptococcus gattii against C. hondurianus and C. bacillisporus(basidiomycota,hymenomycetes,tremellomycetidae)[J]. Taxon,2002,51(4):804-806.
[2]	KIDD S E,HAGEN F,TSCHARKE R L,et al.A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island(British Columbia,Canada)[J]. Proc Natl Acad Sci U S A,2004,101(49):17258-17263.
[3]	HARRIS J R,LOCKHART S R,DEBESS E,et al.Cryptococcus gattii in the United States:clinical aspects of infection with an emerging pathogen[J]. Clin Infect Dis,2011,53(12):1188-1195.
[4]	陈敏,潘炜华,邓淑文,等. 格特隐球菌感染病例临床特征分析[C]. 北京:2012年中国菌物学会学术年会会议摘要,2012.
[5]	窦红涛,万喆,杨启文,等. 格特隐球菌在河北地区引起1例脑膜炎的临床与实验研究[J]. 中国真菌学杂志,2015,10(1):11-15.
[6]	VELEZ N,ESCANDON P.Report on novel environmental niches for Cryptococcus neoformans and Cryptococcus gattii in Colombia:Tabebuia guayacan and Roystonea regia[J]. Med Mycol,2017,55(7):794-797.
[7]	FARRER R A,VOELZ K,HENK D A,et al.Microevolutionary traits and comparative population genomics of the emerging pathogenic fungus Cryptococcus gattii[J]. Philos Trans R Soc Lond B Biol Sci,2016,371(1709):20160021.
[8]	CHEN S C,SLAVIN M A,HEATH C H,et al.Clinical manifestations of Cryptococcus gattii infection:determinants of neurological sequelae and death[J]. Clin Infect Dis,2012,55(6):789-798.
[9]	Centers for Disease Control and Prevention(CDC). Emergence of Cryptococcus gattii-Pacific Northwest,2004-2010[J]. MMWR Morb Mortal Wkly Rep,2010,59(28):865-868.
[10]	SACHT G L,LIMA A M,PERDOMO Y C,et al.Disseminated cryptococcosis with cutaneous involvement in an immunocompetent patient[J]. An Bras Dermatol,2016,91(6):832-834.
[11]	CHEN S,SORRELL T,NIMMO G,et al.Epidemiology and host-and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group[J]. Clin Infect Dis,2000,31(2):499-508.
[12]	CHEN C H,WANG S H,CHEN W L,et al.Ocular complications caused by Cryptococcus gattii AFLP4/VGI meningitis in an immunocompetent host[J]. Rev Inst Med Trop Sao Paulo,2016,58:85.
[13]	MITCHELL D H,SORRELL T C,ALLWORTH A M,et al.Cryptococcal disease of the CNS in immunocompetent hosts:influence of cryptococcal variety on clinical manifestations and outcome[J]. Clin Infect Dis,1995,20(3):611-616.
[14]	LALLOO D,FISHER D,NARAQI N,et al.Cryptococcal meningitis(C. neoformans var. gattii) leading to blindness in previously health Melanesian adults in Papua New Guinea[J]. Q J Med,1994,87(6):343-349.
[15]	MITCHELL D H,SORRELL T C.Pancoast's syndrome due to pulmonary infection with Cryptococcus neoformans variety gattii[J]. Clin Infect Dis,1992,14(5):1142-1144.
[16]	XUE X,WU H,WANG K,et al.Cryptococcosis by Cryptococcus gattii in China[J]. Lancet Infect Dis,2015,15(10):1135-1136.
[17]	HARRIS J R,LOCKHART S R,DEBESS E,et al.Cryptococcus gattii in the United States:clinical aspects of infection with an emerging pathogen[J]. Clin Infect Dis,2011,53(12):1188-1195.
[18]	GALANIS E,MACDOUGALL L,KIDD S,et al.Epidemiology of Cryptococcus gattii,British Columbia,Canada,1999-2007[J]. Emerg Infect Dis,2010,16(2) :251-257.
[19]	SEATON R A,VERMA N,NARAQI S,et al.Visual loss in immunocompetent patients with Cryptococcus neoformans var. gattii meningitis[J]. Trans R Soc Trop Med Hyg,1997,91(1):44-49.
[20]	REX J H,LARSEN R A,DISMUKES W E,et al.Catastrophic visual loss due to Cryptococcus neoformans meningitis[J]. Medicine(Baltimore),1993,72(4):207-224.
[21]	KESTELYN P,TAELMAN H,BOGAERTS J,et al.Ophthalmic manifestations of infections with Cryptococcus neoformans in patients with the acquired immunodeficiency syndrome[J]. Am J Ophthalmol,1993,116(6):721-727.
[22]	MCMULLAN B J,SORRELL T C,CHEN S C.Cryptococcus gattii infections:contemporary aspects of epidemiology,clinical manifestations and management of infection[J]. Future Microbiol,2013,8(12):1613-1631.
[23]	PERFECT J R,DISMUKES W E,DROMER F,et al.Clinical practice guidelines for the management of cryptococcal disease:2010 update by the infectious diseases society of America[J]. Clin Infect Dis,2010,50(3):291-322.
[24]	CHEN S C,KORMAN T K,SLAVIN M A,et al.Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii[J]. Clin Infect Dis,2013,57(4):543-551.
[25]	苏逸丹,汪师贞,翁心华,等. 新型隐球菌临床与环境分离株对抗真菌药物敏感性的比较及血清分型[J]. 中华医学杂志,2000,80(6):448.
[26]	SEATON R A,NARAQI S,WEMBRI J P,et al.Predictors of outcome in Cryptococcus neoformans var. gattii meningitis[J]. QJM,1996,89(6):423-428.
[27]	LAURENSON I F,TREVETT A J,LALLOO D G,et al.Meningitis caused by Cryptococcus neoformans var. gattii and var. neoformans in Papua New Guinea[J]. Trans R Soc Trop Med Hyg,1996, 90(1):57-60.
[28]	CORREA M P,OLIVEIRA E C,DUARTE R R,et al.Cryptococcosis in children in the State of Para,Brazil[J]. Rev Soc Bras Med Trop,1999,32(5):505-508.
[29]	HASIMOTO E SOUZA L K,COSTA C R,FERNANDES ODE F,et al. Clinical and microbiological features of cryptococcal meningitis[J]. Rev Soc Bras Med Trop,2013,46(3):343-347.
[30]	JENNEY A,PANDITHAGE K,FISHER D A,et al.Cryptococcus infection in tropical Australia[J]. J Clin Microbiol,2004,42(8):3865-3868.
[31]	HEITMAN J,KOZEL T R,KWON-CHUNG K J,et al. Cryptococcus:from human pathogen to model yeast[M]. Washington DC:ASM Press,2011:547-564.
[32]	HANSEN J,SLETCHTA E S,GATES-HOLLINGSWORTH M A,et al. Large-scale evaluation of the immuno-mycologics lateral flow and enzyme-linked immunoassays for detection of cryptococcal antigen in serum and cerebrospinal fluid[J]. Clin Vaccine Immunol,2013,20(1):52-55.
[33]	MCMULLAN B J,HALLIDAY C,SORRELL T C,et al.Clinical utility of the cryptococcal antigen lateral flow assay in a diagnostic mycology laboratory[J]. PLoS One,2012,7(11):e49541.
[34]	沈定霞,吴华,薛新颖,等. 刀豆氨酸-甘氨酸-溴麝香草酚蓝培养基在区分格特隐球菌与新生隐球菌中的应用[J]. 临床检验杂志(电子版),2015,4(1):769-773.
[35]	ROBINSON P G,SULITA M J,MATTHEWS E K,et al.Failure of the Bactec 460 radiometer to detect Cryptococcus neoformans fungemia in an AIDS patient[J]. Am J Clin Pathol,1987,87(6):783-786.
[36]	FIRACATIVE C,TRILLES L,MEYER W.MALDI-TOF MS enables the rapid identification of the major molecular types within the Cryptococcus neoformans/C. gattii species complex[J]. PLoS One,2012,7(5):e37566.
[37]	MEYER W,AANENSEN D M,BOEKHOUT T,et al.Consensus multi-locus sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii[J]. Med Mycol,2009,47(6):561-570.